Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director's Dealing

27 Mar 2007 14:54

Chamberlin & Hill PLC27 March 2007 CHAMBERLIN & HILL PLC 27 March 2007 Directors Dealing This notification is made in accordance with section 329 of the Companies Act1985 and Rule 17 of the AIM Rules. On 27 March 2007, the following awards over ordinary shares in the Company weremade under the rules of the Chamberlin & Hill Performance Share Plan and theChamberlin & Hill Share Option Plan to Directors of the Company, as follows: Chamberlin & Hill Performance Share Plan ("PSP") Director Number of Shares held under Award Tim Hair 49,995 Mark Bache 38,457 Adam Vicary 33,843 Under the PSP, awards are structured as nil-cost options granted under theEnterprise Management Incentives Scheme ("EMI Option") contained in Schedule 5to the Income Tax (Earnings and Pensions) Act 2003. No consideration was paid for the grant of the EMI Options. The vesting of an EMI Option is subject to the continued employment of theparticipant and the satisfaction of a performance condition set by theRemuneration Committee of the Company (see below). The EMI Options willnormally become exercisable in three equal tranches on each of the third, fourthand fifth anniversaries of the date of grant subject to the satisfaction of aperformance condition set by the Remuneration Committee of the Company. To theextent that an EMI Option or any part of an EMI Option becomes exercisable, itremains exercisable until the tenth anniversary of the date of grant. The proportion of awards that become exercisable under each tranche of the EMIOption varies on a straight line basis, from 25% to 100%, for average growth inunderlying fully diluted EPS of between 5% p.a. and 10% p.a. above RPI over theperiod between the grant and exercise dates. No options are exercisable ifgrowth is below this range. The base line for the purposes of this calculationis underlying fully diluted EPS, before exceptional and operating one-off costs,for the year ended 31 March 2007. Chamberlin & Hill Share Option Plan ("SOP") Director Number of Shares held under Option Tim Hair 202,282 Mark Bache 103,734 No consideration was paid for the grant of options under the SOP, which arestructured as market value options. The options will normally become exercisable in three equal tranches on each ofthe third, fourth and fifth anniversaries of the date of grant subject to thesatisfaction of performance conditions set by the Remuneration Committee of theCompany (see below). To the extent that an option or any part of an optionbecomes exercisable, it remains exercisable until the tenth anniversary of thedate of grant. The proportion of awards that become exercisable under each tranche of the SOPvaries on a straight line basis, from 25% to 100%, for average growth in TotalShareholder Return of between 15% p.a. and 25% p.a. over the period betweengrant and exercise dates, subject to achieving a minimum average growth inunderlying fully diluted EPS of 5% p.a. above RPI. No options are exercisable ifgrowth is below this range. The option price payable by each participant on the exercise of his option is192.8 pence. The rules of both the EMI Option and the SOP require that total awards, underthese and any other employee share option plan adopted by the company, must notexceed 10% of the Company's ordinary share capital over a 10 year period. Anyaward in excess of this limit would be subject to market purchase. Chamberlin & Hill Executive Share Option Scheme 1997 On 27 March 2007, Tim Hair surrendered for no consideration an option under theChamberlin & Hill Executive Share Option Scheme 1997 over 13,900 ordinary sharesin the Company. The option was granted on 21 June 2006 and had an exerciseprice per share of 215.5 pence. For further information, contact details are:Chamberlin & Hill plcTom Brown, Chairman 01922 707 100 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.